RecruitingNot ApplicableNCT06915831

Type 1 Diabetes and Obstructive Sleep Apnea

Obstructive Sleep Apnea and Glycemic Dysregulation in Adults With Type 1 Diabetes


Sponsor

University of Chicago

Enrollment

40 participants

Start Date

Nov 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at the relationship between Type 1 Diabetes and obstructive sleep apnea (a condition where breathing repeatedly stops during sleep). Researchers want to understand how sleep apnea affects blood sugar control overnight in people using an insulin pump and continuous glucose monitor. **You may be eligible if...** - You are between 18 and 50 years old - You have Type 1 Diabetes and use both an insulin pump and a continuous glucose monitor - Your average blood sugar control (GMI) falls between 5.5% and 8.5% - You have been diagnosed with obstructive sleep apnea (confirmed by a home sleep test) **You may NOT be eligible if...** - You are already regularly using a CPAP machine for sleep apnea - You have had a near-miss driving accident due to sleepiness in the past 6 months - You have had severe low blood sugar episodes in the past 3 months - You have had a heart attack or stroke in the past 6 months - You have advanced kidney disease, proliferative eye disease, or severe high blood pressure - You work night shifts Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous positive airway pressure (CPAP)

All-night CPAP will be applied with bedtimes 23:00h to 7:00h.


Locations(1)

University of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06915831


Related Trials